Chicago, IL, United States of America

Thomas Kurth

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Innoblative Designs, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Thomas Kurth in Tissue Ablation Technology

Introduction

Thomas Kurth is an accomplished inventor based in Chicago, IL, known for his significant contributions to medical technology. He has developed innovative solutions aimed at improving surgical procedures, particularly in the field of tissue ablation.

Latest Patents

One of Kurth's notable patents is for a device titled "Screen sphere tissue ablation devices and methods." This invention features an ablation device designed with a screen sphere configuration, specifically for the ablation of marginal tissue surrounding a tissue cavity. The device comprises a probe with a nonconductive elongated shaft that includes at least one lumen. Additionally, it has a nonconductive distal portion extending from the shaft, which contains multiple distal and proximal ports that communicate with the lumen. The device is equipped with an electrode array consisting of independent conductive wires that are strategically positioned along the external surface of the nonconductive distal portion.

Career Highlights

Thomas Kurth has made a significant impact in the medical device industry through his work at Innoblative Designs, Inc. His innovative approach to tissue ablation technology has positioned him as a key figure in advancing surgical techniques. With a focus on enhancing patient outcomes, Kurth's inventions reflect his commitment to improving healthcare.

Collaborations

Throughout his career, Kurth has collaborated with talented professionals, including Robert F. Rioux and Alyssa Bailey. These partnerships

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…